BD (Becton, Dickinson and Company) has announced the global commercial release of new configurations of its BD FACSDiscover™ A8 Cell Analyzers, expanding access to advanced spectral and real-time imaging cell analysis for laboratories of all sizes. The new analyzers, featuring BD SpectralFX™ Technology and BD CellView™ Image technology, enable scientists to analyze up to 50 or more characteristics of a single cell with high resolution and sensitivity. This launch aims to support academic, pharmaceutical, and biotech labs in advancing research in immunology, cancer immunotherapy, and cell biology. The analyzers are now available to order through local sales representatives, with flexible financing options offered to accommodate different budget needs.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. BD - Becton, Dickinson and Company published the original content used to generate this news brief via PR Newswire (Ref. ID: NY37748) on December 03, 2025, and is solely responsible for the information contained therein.
Comments